TipRanks
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1

Compare Vertex Pharmaceuticals (VX1) vs. Competitors

23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Vertex Pharmaceuticals
€475.00
€114.07B
29.14
27.43%
21 Buy
3 Hold
1 Sell
Strong Buy
Alnylam Pharma
$240.08
$30.93B
36.02
-52.34%
18 Buy
4 Hold
0 Sell
Strong Buy
BioMarin Pharmaceutical
$66.12
$11.31B
150.47
2.90%
17 Buy
5 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$18.92
$1.86B
-12.15
-21.70%
4 Buy
9 Hold
4 Sell
Hold
Intellia Therapeutics
$13.51
$1.70B
-3.65
-40.02%
6 Buy
4 Hold
2 Sell
Moderate Buy
Crispr Therapeutics AG
$60.90
$5.36B
-11.64
-23.88%
8 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:VX1
Vertex Pharmaceuticals
446.40
102.75
29.90%
ALNY
Alnylam Pharma
219.72
-232.28
-51.39%
BMRN
BioMarin Pharmaceutical
57.18
1.57
2.82%
SRPT
Sarepta Therapeutics
17.50
-5.76
-24.76%
NTLA
Intellia Therapeutics
12.26
-8.28
-40.31%
CRSP
Crispr Therapeutics AG
55.43
-14.76
-21.03%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts